VAN ECK ASSOCIATES CORP - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$243
-58.5%
15,073
+6.8%
0.00%0.0%
Q2 2023$586
-39.6%
14,114
-12.6%
0.00%
-50.0%
Q1 2023$971
-19.2%
16,151
-1.4%
0.00%
-33.3%
Q4 2022$1,201
-99.9%
16,377
+21.0%
0.00%0.0%
Q3 2022$1,028,000
+9.7%
13,532
+0.3%
0.00%
+50.0%
Q2 2022$937,000
-37.7%
13,486
-25.7%
0.00%
-33.3%
Q1 2022$1,503,000
+10.9%
18,147
+0.6%
0.00%0.0%
Q4 2021$1,355,000
-38.9%
18,046
-5.5%
0.00%
-50.0%
Q3 2021$2,219,000
-51.5%
19,105
-7.4%
0.01%
-45.5%
Q2 2021$4,578,000
+81.5%
20,638
+8.1%
0.01%
+57.1%
Q1 2021$2,522,000
-22.5%
19,083
+1.5%
0.01%
-22.2%
Q4 2020$3,253,000
-49.1%
18,802
-67.3%
0.01%
-10.0%
Q3 2020$6,392,000
+91.7%
57,428
+2.1%
0.01%
+66.7%
Q2 2020$3,334,000
+77.6%
56,232
+101.7%
0.01%
-40.0%
Q1 2020$1,877,000
-17.3%
27,873
+3.5%
0.01%
+11.1%
Q4 2019$2,269,000
+16.3%
26,920
+3.2%
0.01%0.0%
Q3 2019$1,951,000
+18.7%
26,090
+0.3%
0.01%
+12.5%
Q2 2019$1,644,000
+49.0%
26,002
+13.6%
0.01%
+60.0%
Q1 2019$1,103,000
+47.3%
22,891
+2.4%
0.01%
+25.0%
Q4 2018$749,000
-24.8%
22,359
+17.6%
0.00%
-20.0%
Q3 2018$996,000
+77.5%
19,014
+6.1%
0.01%
+66.7%
Q2 2018$561,000
+34.2%
17,925
-6.4%
0.00%
+50.0%
Q1 2018$418,000
+15.8%
19,152
+7.2%
0.00%0.0%
Q4 2017$361,000
-5.5%
17,874
-7.0%
0.00%0.0%
Q3 2017$382,000
+20.1%
19,224
+4.7%
0.00%0.0%
Q2 2017$318,00018,3660.00%
Other shareholders
NOVOCURE LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders